Applications of new laboratory marker assays in neurological diagnoses - a pilot study
- PMID: 16601767
- DOI: 10.5507/bp.2005.037
Applications of new laboratory marker assays in neurological diagnoses - a pilot study
Abstract
225 consecutive patients with different neurological diseases and 101 individuals as the control were examined between 2002-2004. Cystatin C, arginase-I, tau-protein and beta-amyloid were measured. Individuals with CNS inflammation had significantly lower Cystatin-C index (CSF/serum) values. There was no diagnostic significance of the Arginase-I assay in CSF was verified. The CSF tau-protein/beta-amyloid index was shown to be a sufficient efficacy for neurodegenerative disease diagnosis.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous